NVIV Insider Trading Activity and SEC Form 4 Filings
NVIV insider trading summary
No open-market insider purchases or sales of Invivo Therapeutics Holdings Corp. (NVIV) have been reported on SEC Form 4 in the past 12 months.
Latest NVIV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 6, 2023 | Brice Foose | 10% Owner | Buy | $19K (37,000 @ $0.50) |
| Feb 6, 2023 | Brice Foose | 10% Owner | Buy | $13K (35,000 @ $0.36) |
| Feb 6, 2023 | Brice Foose | 10% Owner | Buy | $12K (33,000 @ $0.35) |
| Feb 6, 2023 | Brice Foose | 10% Owner | Buy | $30K (51,000 @ $0.59) |
| Feb 6, 2023 | Brice Foose | 10% Owner | Buy | $3K (8,000 @ $0.34) |
| Feb 5, 2023 | Brice Foose | 10% Owner | Buy | $9K (36,000 @ $0.26) |
| Feb 5, 2023 | Brice Foose | 10% Owner | Buy | $4K (13,000 @ $0.30) |
| Feb 5, 2023 | Brice Foose | 10% Owner | Buy | $13K (48,000 @ $0.28) |
| Feb 5, 2023 | Brice Foose | 10% Owner | Buy | $11K (37,000 @ $0.31) |
| Feb 5, 2023 | Brice Foose | 10% Owner | Buy | $3K (12,000 @ $0.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.